title: MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.
abstract: OBJECTIVE
  The Multidomain Alzheimer Preventive Trial (MAPT study) was designed to assess the efficacy of isolated supplementation with omega-3 fatty acid, an isolated multidomain intervention (consisting of nutritional counseling, physical exercise, cognitive stimulation) or a combination of the two interventions on the change of cognitive functions in frail subjects aged 70 years and older for a period of 3 years. Ancillary neuroimaging studies were additionally implemented to evaluate the impact of interventions on cerebral metabolism (FDG PET scans) and atrophy rate (MRIs), as well as brain amyloïd deposit (AV45 PET scans).
  1680 subjects (mean age: 75.3 years; female: 64.8 %), enrolled by 13 memory clinics, were randomized into one of the following four groups: omega-3 supplementation alone, multidomain intervention alone, omega-3 plus multidomain intervention, or placebo. Participants underwent cognitive, functional and biological assessments at M6, M12, M24 and M36 visits. The primary endpoint is a change of memory function at 3 years, as assessed by the Free and Cued Selective Reminding test. All participants will be followed for 2 additional years after the 3-years intervention (MAPT PLUS extension study).
  
  
  METHODS
  1/Omega-3 supplementation: two soft capsules daily as a single dose, containing a total of 400 mg docosahexaenoic acid (DHA), i.e., 800 mg docosahexaenoic acid per day, for 3 years. 2/ Multidomain intervention: collective training sessions conducted in small groups (6-8 participants) in twelve 120-minute sessions over the first 2 months (two sessions a week for the first month, and one session a week the second month) then a 60-minute session per month in the following three areas: nutrition, physical activity, and cognition until the end of the 3 years. In addition to the collective sessions, individualized preventive outpatient visits exploring possible risk factors for cognitive decline are performed at baseline, M12 and M24.
  For cognition, the mean MMSE at baseline was 28.1 (± 1.6). About 58% and 42% of participants had a CDR score equal to 0 and 0.5, respectively. Regarding mobility status, 200 (11.9%) had a 4-m gait speed lower or equal to 0.8 m/s. According to the Fried criteria, 673 (42.1%) participants were considered pre frail, and 51 (3.2%) frail. The red blood cell DHA content was 26.1 ± 8.1 µg/g. Five hundred and three participants underwent baseline MRI. AV45 PET scans were performed in 271 individuals and preliminary results showed that 38.0% had a cortical SUVR > 1.17, which gave an indication of significant brain amyloïd deposit. DISCUSSION: The MAPT trial is presently the first largest and longest multidomain preventive trial relevant to cognitive decline in older adults with subjective memory complaints. The multidomain intervention designed for the MAPT trial is likely to be easily implemented within the general population.
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: B
authors.initials: B
authors.lastname: Vellas
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France.
authors.forename: I
authors.initials: I
authors.lastname: Carrie
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: S
authors.initials: S
authors.lastname: Gillette-Guyonnet
authors.affiliation: Department of Neurology, Memory Research Resource Center for Alzheimer's Disease, University Hospital of Montpellier, Montpellier, France.
authors.forename: J
authors.initials: J
authors.lastname: Touchon
authors.affiliation: Geriatrics Department, Memory Research Resource Center, University Hospital of Limoges, Limoges, France.
authors.forename: T
authors.initials: T
authors.lastname: Dantoine
authors.affiliation: INSERM U897, Memory Research Resource Center for Alzheimer's Disease, University Hospital of Bordeaux, Bordeaux, France.
authors.forename: J F
authors.initials: JF
authors.lastname: Dartigues
authors.affiliation: Geriatrics Department, Hospital of Castres, Castres, France.
authors.forename: M N
authors.initials: MN
authors.lastname: Cuffi
authors.affiliation: Geriatrics Department, Hospital of Tarbes, Tarbes, France.
authors.forename: S
authors.initials: S
authors.lastname: Bordes
authors.affiliation: Geriatrics Department, Hospital of Tarbes, Tarbes, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Gasnier
authors.affiliation: Memory Research Resource Center, University Hospital of Nice, Nice, France.
authors.forename: P
authors.initials: P
authors.lastname: Robert
authors.affiliation: Geriatrics Department, Hospital of Foix, Foix, France.
authors.forename: L
authors.initials: L
authors.lastname: Bories
authors.affiliation: Memory Research Resource Center, Neurology Department, University Hospital of Dijon, Dijon, France.
authors.forename: O
authors.initials: O
authors.lastname: Rouaud
authors.affiliation: Geriatrics Department, Hospital of Lavaur, Lavaur, France.
authors.forename: F
authors.initials: F
authors.lastname: Desclaux
authors.affiliation: Geriatrics Department, Hospital of Montauban, Montauban, France.
authors.forename: K
authors.initials: K
authors.lastname: Sudres
authors.affiliation: Geriatrics Department, Centre Hospitalier Lyon-Sud, Lyon, France.
authors.forename: M
authors.initials: M
authors.lastname: Bonnefoy
authors.affiliation: Geriatrics Department, Hospital of Princess Grace, Monaco.
authors.forename: A
authors.initials: A
authors.lastname: Pesce
authors.affiliation: INSERM Center U897, CIC-EC7, Bordeaux University, Department of Public Health of CHU Bordeaux, Bordeaux, France.
authors.forename: C
authors.initials: C
authors.lastname: Dufouil
authors.affiliation: Neuroradiology Department, Pitié-Salpêtrière Hospital, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Lehericy
authors.affiliation: Neuroradiology Department, Pitié-Salpêtrière Hospital, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Chupin
authors.affiliation: CATI, NeuroSpin, CEA-Saclay Center, Gif-sur-Yvette, France.
authors.forename: J F
authors.initials: JF
authors.lastname: Mangin
authors.affiliation: INSERM UMR 825, Toulouse, France ; Department of Nuclear Medicine, CHU Toulouse, Purpan University Hospital, Toulouse, France.
authors.forename: P
authors.initials: P
authors.lastname: Payoux
authors.affiliation: INSERM UMR 825, Toulouse, France.
authors.forename: D
authors.initials: D
authors.lastname: Adel
authors.affiliation: Nutrition Department, Agrocampus-INRA, Rennes, France.
authors.forename: P
authors.initials: P
authors.lastname: Legrand
authors.affiliation: Nutrition Department, Agrocampus-INRA, Rennes, France.
authors.forename: D
authors.initials: D
authors.lastname: Catheline
authors.affiliation: Institut de Recherche Pierre Fabre, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Kanony
authors.affiliation: Institut de Recherche Pierre Fabre, Toulouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Zaim
authors.affiliation: INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France ; Department of Medical Information, CHU Toulouse, Toulouse, France.
authors.forename: L
authors.initials: L
authors.lastname: Molinier
authors.affiliation: INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France ; Department of Medical Information, CHU Toulouse, Toulouse, France.
authors.forename: N
authors.initials: N
authors.lastname: Costa
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France.
authors.forename: J
authors.initials: J
authors.lastname: Delrieu
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: T
authors.initials: T
authors.lastname: Voisin
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Faisant
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France.
authors.forename: F
authors.initials: F
authors.lastname: Lala
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: F
authors.initials: F
authors.lastname: Nourhashémi
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Rolland
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: G Abellan
authors.initials: GA
authors.lastname: Van Kan
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Dupuy
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: C
authors.initials: C
authors.lastname: Cantet
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: P
authors.initials: P
authors.lastname: Cestac
authors.affiliation: Research Center, Institut Universitaire de Gériatrie de Montréal, Montréal, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Belleville
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Washington, Washington, USA.
authors.forename: S
authors.initials: S
authors.lastname: Willis
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: M
authors.initials: M
authors.lastname: Cesari
authors.affiliation: University of California, San Francisco, California, United States.
authors.forename: M W
authors.initials: MW
authors.lastname: Weiner
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: M E
authors.initials: ME
authors.lastname: Soto
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France.
authors.forename: P J
authors.initials: PJ
authors.lastname: Ousset
authors.affiliation: Gérontopôle, Department of Geriatrics, CHU Toulouse, Purpan University Hospital, Toulouse, France ; INSERM UMR 1027, Toulouse, France ; University of Toulouse III, Toulouse, France ; Department of Epidemiology and Public Health, CHU Toulouse, Toulouse, France.
authors.forename: S
authors.initials: S
authors.lastname: Andrieu
keywords: Alzheimer’s disease; Multidomain intervention; Omega-3 fatty acids; Prevention